Fox Run Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,650
Closed -$212K 1155
2025
Q2
$212K Sell
2,650
-310
-10% -$25.9K 0.04% 738
2025
Q1
$254K Buy
+2,960
New +$243K 0.04% 725
2020
Q1
Sell
-9,247
Closed -$375K 301
2019
Q4
$375K Sell
9,247
-1,701
-16% -$63.5K 0.3% 114
2019
Q3
$380K Buy
+10,948
New +$361K 0.35% 90
2018
Q2
Sell
-10,234
Closed -$345K 853
2018
Q1
$345K Buy
10,234
+4,590
+81% +$176K 0.08% 444
2017
Q4
$251K Sell
5,644
-356
-6% -$16.2K 0.07% 516
2017
Q3
$301K Buy
+6,000
New +$307K 0.09% 482
2016
Q4
Sell
-15,100
Closed -$729K 628
2016
Q3
$729K Buy
15,100
+9,400
+165% +$475K 0.43% 21
2016
Q2
$316K Sell
5,700
-6,000
-51% -$331K 0.15% 270
2016
Q1
$625K Buy
+11,700
New +$576K 0.42% 39

Other funds holding PBH

Fox Run Management's PBH Position: Q3 2025 in Review

Fox Run Management sold out of Prestige Consumer Healthcare (PBH) in Q3 2025, closing a stake of 2,650 shares — an estimated $212K sold.

Fox Run Management first reported a position in PBH in Q1 2016 and held it in 10 quarters. The position peaked at $729K in Q3 2016. 356 funds tracked by Wall St. Rank hold PBH as of Q3 2025.

  • Fox Run Management reported no remaining Prestige Consumer Healthcare position as of Q3 2025 after selling out during the quarter.
  • Fox Run Management sold 2,650 Prestige Consumer Healthcare shares in Q3 2025, an estimated $212K.
  • Fox Run Management first reported a position in Prestige Consumer Healthcare in Q1 2016 and held it in 10 quarters.
  • Fox Run Management's Prestige Consumer Healthcare position peaked at $729K in Q3 2016.
  • 356 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2025.

Based on Fox Run Management's 13F filing for Q3 2025, filed 12 Nov 2025.